Trividia Health Initiates Voluntary Recall of Select TRUE METRIX® Blood Glucose Meters Due to Potential LCD Display Defect
Trividia Health, Inc. has announced a voluntary recall affecting a limited number of TRUE METRIX® Self-Monitoring Blood Glucose Meters that were co-branded under the Good Neighbor Pharmacy® label and distributed across the United States. This proactive measure is being taken to address a potential defect in the liquid crystal display (LCD) of the affected devices, which could compromise the accuracy and readability of blood glucose test results. While no injuries or adverse events have been reported to date, Trividia Health is prioritizing patient safety by initiating this recall in close coordination with the U.S. Food and Drug Administration (FDA).
The recall specifically targets 601 units from a single production lot—Lot Number KD0746—manufactured on September 4, 2025, and distributed between September 8 and September 16, 2025. These meters were sold exclusively under the Good Neighbor Pharmacy® brand, a trusted name in community pharmacy services. Trividia Health identified the issue during routine quality assurance testing and internal product evaluations, which revealed that a small subset of meters from this lot may exhibit LCD display anomalies.
The potential defect involves partial or missing numerical segments on the screen, as well as “ghosting”—a phenomenon where digits or characters appear faint, blurred, or persist after the display should have cleared. Such visual irregularities could lead users to misread their blood glucose levels or experience delays in obtaining accurate results. For individuals managing diabetes, especially those prone to hypoglycemia (dangerously low blood sugar), timely and precise readings are critical. A misinterpreted or delayed result could, in rare circumstances, lead to inappropriate treatment decisions or a failure to administer necessary glucose or medical intervention promptly.
Importantly, Trividia Health emphasizes that this issue is isolated to a very small batch of meters and does not reflect a systemic problem with the TRUE METRIX® product line. The company has received no reports of patient harm, adverse events, or injuries related to this specific defect. Nevertheless, in alignment with its commitment to quality and consumer safety, Trividia Health is taking immediate corrective action to remove the potentially affected units from circulation and provide replacements to impacted customers.
To assist consumers in determining whether their device is part of the recall, Trividia Health has established multiple convenient verification methods. First, individuals can check the lot number printed on the side of the original product packaging; if it reads “KD0746,” the meter is included in the recall. Second, consumers can locate the serial number on the back of their TRUE METRIX® meter and use it to verify recall status through Trividia Health’s dedicated online portal at . This website features a user-friendly search tool that instantly cross-references serial numbers with the affected lot.
For those who prefer direct assistance, Trividia Health’s Customer Care Department is available toll-free at 1-888-835-2723, Monday through Friday from 8:00 AM to 8:00 PM Eastern Standard Time (excluding holidays). Trained representatives can help customers identify whether their meter is affected by reviewing the serial number and guiding them through next steps. Alternatively, consumers may reach out via email at to request support in verifying their device and arranging for a replacement if necessary.
Customers confirmed to have an affected meter will be provided with clear instructions for returning the device and receiving a free replacement. Trividia Health assures users that this process will be handled efficiently and with minimal inconvenience. Importantly, individuals who own TRUE METRIX® meters from other lots—or those not co-branded with Good Neighbor Pharmacy®—are not impacted by this recall and may continue using their devices as intended without concern.
In addition to consumer outreach, Trividia Health is actively notifying its distribution network, including retail pharmacies, mail-order providers, and wholesale distributors across the United States. These partners are being asked to identify and remove any remaining units from Lot KD0746 from their inventory and shelves. The company is working diligently to ensure full traceability and accountability throughout the supply chain to prevent further distribution of the affected meters.
This voluntary recall underscores Trividia Health’s unwavering commitment to patient safety and product integrity. As a leading provider of diabetes care solutions, the company maintains rigorous quality control standards at every stage of manufacturing, testing, and distribution. The swift identification and resolution of this issue reflect Trividia Health’s proactive approach to risk management and its dedication to transparency with both healthcare providers and end users.
The FDA classifies medical device recalls based on the level of health risk they pose. While the agency has not yet assigned a formal classification to this action, Trividia Health’s voluntary recall aligns with best practices for addressing potential device malfunctions that could impact clinical decision-making—even in the absence of confirmed injuries. By acting preemptively, the company aims to prevent any possible harm and reinforce trust in its products.
Diabetes management relies heavily on accurate, real-time data, and blood glucose meters serve as essential tools for millions of Americans. A malfunctioning display—even if rare—can disrupt this critical feedback loop. Trividia Health recognizes the anxiety such issues may cause and is committed to supporting affected customers with empathy, speed, and clarity.
Consumers with additional questions or concerns are encouraged to consult their healthcare provider, especially if they rely on frequent glucose monitoring for treatment decisions. However, it is important to stress that only meters from Lot KD0746 are involved in this recall, and the vast majority of TRUE METRIX® users are unaffected.
In conclusion, while the scope of this recall is narrow—limited to just 601 units from a single lot—Trividia Health is treating it with the utmost seriousness. The company’s coordinated response, transparent communication, and customer-focused resolution process exemplify its core values and dedication to the diabetes community. Patients and caregivers can rest assured that Trividia Health continues to prioritize safety, reliability, and excellence in every product it brings to market.
Trividia Health remains vigilant in its mission to empower individuals with diabetes through innovative, trustworthy, and accessible health solutions.
